Financial Performance - The company's operating revenue for Q1 2024 was ¥126,555,144.11, a decrease of 19.05% compared to ¥156,340,882.84 in the same period last year[4] - Net profit attributable to shareholders was ¥10,679,390.41, down 67.88% from ¥33,252,865.25 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥3,803,838.29, reflecting an 81.33% decline from ¥20,374,484.03 in the previous year[4] - Total profit decreased by 68.14% year-on-year to CNY 12,391,423.64, primarily due to a decline in operating income and gross margin[9] - Net profit fell by 67.88% year-on-year to CNY 10,679,390.41, reflecting the significant drop in total profit[9] - The company’s diluted earnings per share decreased by 67.07% to ¥0.081 compared to ¥0.246 in the same period last year[4] - The basic earnings per share for Q1 2024 was CNY 0.082, down from CNY 0.246 in Q1 2023, reflecting a decrease of approximately 66.7%[23] - The total profit for Q1 2024 was CNY 12,391,423.64, compared to CNY 38,888,190.97 in Q1 2023, indicating a decline of about 68.2%[22] Cash Flow and Assets - The net cash flow from operating activities increased by 75.62% to ¥65,494,979.38, compared to ¥37,293,788.25 in the same period last year[4] - Cash and cash equivalents increased to 473.49 million yuan from 421.55 million yuan[17] - Cash and cash equivalents at the end of Q1 2024 stood at CNY 462,248,056.69, up from CNY 126,624,430.68 at the end of Q1 2023, marking an increase of approximately 265.5%[27] - Investment activities generated a net cash flow of CNY 160,703,328.16 in Q1 2024, a significant improvement from a negative cash flow of CNY 67,068,869.87 in Q1 2023[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,564,378,268.13, a decrease of 5.43% from ¥2,711,573,354.46 at the end of the previous year[4] - Shareholders' equity attributable to the parent company was ¥2,328,915,991.68, down 6.33% from ¥2,486,173,137.43 at the end of the previous year[4] - Total liabilities increased to 235.46 million yuan from 225.40 million yuan[19] - Non-current liabilities rose to 81.77 million yuan from 53.79 million yuan[19] Revenue and Costs - Revenue decreased by 19.05% year-on-year, primarily due to inventory destocking by key customers and a reduction in demand for vaccine rubber stoppers, resulting in a revenue decline of 12.9164 million yuan[15] - The total operating costs for Q1 2024 were CNY 123,653,466.66, a decrease from CNY 133,470,456.13 in Q1 2023, representing a reduction of approximately 7.5%[22] - The company reported total revenue from sales of goods and services of CNY 160,093,880.48 in Q1 2024, compared to CNY 172,773,190.07 in Q1 2023, a decrease of about 7.4%[25] Government Subsidies and Other Income - The company received government subsidies amounting to ¥1,342,719.00, which are closely related to its normal business operations[6] - Other income decreased by 69.86% to CNY 2,035,848.82, attributed to a reduction in government subsidies received[9] - Cash received from government subsidies increased by 137.64% to CNY 44,480,349.49, indicating a positive cash flow from this source[9] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,444, with no preferred shareholders[11] - The top shareholder, Jiangyin Hualan Electromechanical Technology Co., Ltd., holds 21.86% of the shares, totaling 28,280,000 shares[12] Research and Development - Research and development expenses increased to CNY 11,096,955.18 in Q1 2024, compared to CNY 8,655,646.30 in Q1 2023, reflecting a growth of approximately 28.2%[22] Other Observations - The company did not receive any cash from new investments or bank loans during the period, indicating a lack of new financing activities[9] - The company did not report any significant new product launches or technological advancements during this quarter[30]
华兰股份(301093) - 2024 Q1 - 季度财报